Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

1.640

+0.130 (8.61%)

At close: Jun 26, 2026, 4:00 PM EDT

1.600

-0.040 (-2.44%)

After-hours: Jun 26, 2026, 7:12 PM EDT

Neumora Therapeutics Employees

Neumora Therapeutics had 92 employees as of March 31, 2026. The number of employees decreased by 4 or -4.17% since the number was last reported on December 31, 2025.

Employees

Change

-4

Growth

-4.17%

Revenue / Employee

n/a

Profits / Employee

-$2,417,326

Market Cap

303.87M

Employees Chart

Employees History

Date	Employees	Change	Growth
Mar 31, 2026	92	-4	-4.17%
Dec 31, 2025	96	-14	-12.73%
Dec 31, 2024	110	-14	-11.29%
Dec 31, 2023	124	30	31.91%
Dec 31, 2022	94	6	6.82%
Dec 31, 2021	Pro	Pro	Pro
Dec 31, 2020	Pro	Pro	Pro

Related Stocks

Company Name	Employees
MacroGenics	293
Bicycle Therapeutics	288
Abeona Therapeutics	226
Zentalis Pharmaceuticals	106
SAB Biotherapeutics	86
Lineage Cell Therapeutics	77
Immuneering	55
Surrozen	44

Employee Rankings

NMRA News

9 days ago - Neumora Therapeutics price target lowered to $4 from $6 at Mizuho - TheFly
10 days ago - Neumora Therapeutics Slides: Investor presentation - Filings
11 days ago - Neumora Therapeutics price target lowered to $5 from $8 at Needham - TheFly
11 days ago - Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright - TheFly
11 days ago - Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102 - TheFly
12 days ago - Neumora Therapeutics announces KOASTAL studies miss primary endpoint - TheFly
12 days ago - Neumora Therapeutics scraps depression drug after two late-stage trial failures - Reuters
12 days ago - Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update - GlobeNewsWire

More News